Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial (Q41692347)
Jump to navigation
Jump to search
scientific article published on June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial |
scientific article published on June 2015 |
Statements
1 reference
Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial (English)
1 reference
György Losonczy
1 reference
Aleksandra Szczesna
1 reference
Nick Thatcher
1 reference
Fred R Hirsch
1 reference
Alexander V Luft
1 reference
Tudor E Ciuleanu
1 reference
Mircea Dediu
1 reference
Rinat K Galiulin
1 reference
Beatrix Bálint
1 reference
Andrzej Kazarnowicz
1 reference
Keunchil Park
1 reference
Christian Schumann
1 reference
Martin Reck
1 reference
Henrik Depenbrock
1 reference
Shivani Nanda
1 reference
Anamarija Kruljac-Letunic
1 reference
Raffael Kurek
1 reference
Luis Paz-Ares
1 reference
Mark A Socinski
1 reference
SQUIRE Investigators
1 reference
1 June 2015
1 reference
1 reference
16
1 reference
7
1 reference
763-774
1 reference
Identifiers
1 reference
1 reference